Home / Latest Reports / Angioedema Treatment Market

Angioedema Treatment Market by Type and Application - Global Industry Analysis & Forecast to 2027

Published On : November 2019 Pages : 150 Category: Pharma & Healthcare Report Code : HC117022

Request Sample Inquiry Before Buying Request for Customization Check Discount

Angioedema Treatment Market by Type (Corticosteroids, Antihistamines, Others) Application (Hospitals, Clinics, Research Organizations) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The angioedema treatment market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Angioedema is a swelling of the area underneath the skin, like urticaria, or hives. Angioedema influences the deeper layers, including the subcutaneous tissue, dermis, the mucosa, and submucosal tissues. The treatment for angioedema relies upon the cause, however, the most significant activity is to guarantee a free airway.  

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Angioedema Treatment Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • AstraZeneca
  • Merck & Co.
  • F.Hoffmann-La Roche AG
  • Sanofi SA
  • Valeant Pharmaceuticals International
  • AstraZeneca
  • GlaxoSmithKline

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Angioedema Treatment Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o    Corticosteroids

o    Antihistamines

o    Others

·         Angioedema Treatment Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o    Hospitals

o    Clinics

o    Research Organizations

·         Angioedema Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    AstraZeneca

o    Merck & Co.

o    F.Hoffmann-La Roche AG

o    Sanofi SA

o    Valeant Pharmaceuticals International

o    AstraZeneca

o    GlaxoSmithKline

·         Angioedema Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Angioedema Treatment Market, By Country

o    U.S. Angioedema Treatment Market

o    Canada Angioedema Treatment Market

o    Mexico Angioedema Treatment Market

o    Europe

§  Europe Angioedema Treatment Market, By Country

o    Germany Angioedema Treatment Market

o    UK Angioedema Treatment Market

o    France Angioedema Treatment Market

o    Russia Angioedema Treatment Market

o    Italy Angioedema Treatment Market

o    Rest of Europe Angioedema Treatment Market

o    Asia-Pacific

§  Asia-Pacific Angioedema Treatment Market, By Country

o    China Angioedema Treatment Market

o    Japan Angioedema Treatment Market

o    South Korea Angioedema Treatment Market

o    India Angioedema Treatment Market

o    Southeast Asia Angioedema Treatment Market

o    Rest of Asia-Pacific Angioedema Treatment Market

o    South America

§  South America Angioedema Treatment Market

o    Brazil Angioedema Treatment Market

o    Argentina Angioedema Treatment Market

o    Columbia Angioedema Treatment Market

o    Rest of South America Angioedema Treatment Market

o    Middle East and Africa

§  Middle East and Africa Angioedema Treatment Market

o    Saudi Arabia Angioedema Treatment Market

o    UAE Angioedema Treatment Market

o    Egypt Angioedema Treatment Market

o    Nigeria Angioedema Treatment Market

o    South Africa Angioedema Treatment Market

o    Rest of MEA Angioedema Treatment Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Angioedema Treatment Market, By Type

5.1.     Introduction

5.2.     Global Angioedema Treatment Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Angioedema Treatment Revenue and Revenue Share by Type (2017-2027)

5.3.     Corticosteroids

5.3.1.  Global Corticosteroids Revenue and Growth Rate (2017-2027)

5.4.     Antihistamines

5.4.1.  Global Antihistamines Revenue and Growth Rate (2017-2027)

5.5.     Others

5.5.1.  Global Others Revenue and Growth Rate (2017-2027)

6.       Angioedema Treatment Market, By Application

6.1.     Introduction

6.2.     Global Angioedema Treatment Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Angioedema Treatment Revenue and Revenue Share by Application (2017-2027)

6.3.     Hospitals

6.3.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

6.4.     Clinics

6.4.1.  Global Clinics Revenue and Growth Rate (2017-2027)

6.5.     Research Organizations

6.5.1.  Global Research Organizations Revenue and Growth Rate (2017-2027)

7.       Angioedema Treatment Market, By Region

7.1.     Introduction

7.2.     Global Angioedema Treatment Revenue and Market Share by Regions

7.2.1.  Global Angioedema Treatment Revenue by Regions (2017-2027)

7.3.     North America Angioedema Treatment by Countries

7.3.1.  North America Angioedema Treatment Revenue and Growth Rate (2017-2027)

7.3.2.  North America Angioedema Treatment Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Angioedema Treatment by Countries

7.4.1.  Europe Angioedema Treatment Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Angioedema Treatment Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Angioedema Treatment by Countries

7.5.1.  Asia-Pacific Angioedema Treatment Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Angioedema Treatment Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Angioedema Treatment by Countries

7.6.1.  South America Angioedema Treatment Revenue and Growth Rate (2017-2027)

7.6.2.  South America Angioedema Treatment Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Angioedema Treatment by Countries

7.7.1.  Middle East and Africa Angioedema Treatment Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Angioedema Treatment Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     AstraZeneca

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Merck & Co.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     F.Hoffmann-La Roche AG

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Sanofi SA

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Valeant Pharmaceuticals International

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     AstraZeneca

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     GlaxoSmithKline

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

9.       Angioedema Treatment Market Forecast (2017-2027)

9.1.     Global Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Angioedema Treatment Market Forecast by Regions (2017-2027)

9.2.1.  North America Angioedema Treatment Market Forecast (2017-2027)

9.2.1.1.  United States Angioedema Treatment Market Forecast (2017-2027)

9.2.1.2.  Canada Angioedema Treatment Market Forecast (2017-2027)

9.2.1.3.  Mexico Angioedema Treatment Market Forecast (2017-2027)

9.2.2.  Europe Angioedema Treatment Market Forecast (2017-2027)

9.2.2.1.  Germany Angioedema Treatment Market Forecast (2017-2027)

9.2.2.2.  France Angioedema Treatment Market Forecast (2017-2027)

9.2.2.3.  UK Angioedema Treatment Market Forecast (2017-2027)

9.2.2.4.  Russia Angioedema Treatment Market Forecast (2017-2027)

9.2.2.5.  Italy Angioedema Treatment Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Angioedema Treatment Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Angioedema Treatment Market Forecast (2017-2027)

9.2.3.1.  China Angioedema Treatment Market Forecast (2017-2027)

9.2.3.2.  Japan Angioedema Treatment Market Forecast (2017-2027)

9.2.3.3.  Korea Angioedema Treatment Market Forecast (2017-2027)

9.2.3.4.  India Angioedema Treatment Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Angioedema Treatment Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Angioedema Treatment Market Forecast (2017-2027)

9.2.4.  South America Angioedema Treatment Market Forecast (2017-2027)

9.2.4.1.  Brazil Angioedema Treatment Market Forecast (2017-2027)

9.2.4.2.  Argentina Angioedema Treatment Market Forecast (2017-2027)

9.2.4.3.  Columbia Angioedema Treatment Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Angioedema Treatment Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Angioedema Treatment Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Angioedema Treatment Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Angioedema Treatment Market Forecast (2017-2027)

9.2.5.3.  Egypt Angioedema Treatment Market Forecast (2017-2027)

9.2.5.4.  Nigeria Angioedema Treatment Market Forecast (2017-2027)

9.2.5.5.  South Africa Angioedema Treatment Market Forecast (2017-2027)

9.2.5.6.  Turkey Angioedema Treatment Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Angioedema Treatment Market Forecast (2017-2027)

9.3.     Angioedema Treatment Market Forecast by Type (2017-2027)

9.3.1.  Angioedema Treatment Forecast by Type (2017-2027)

9.3.2.  Angioedema Treatment Market Share Forecast by Type (2017-2027)

9.4.     Angioedema Treatment Market Forecast by Application (2017-2027)

9.4.1.  Angioedema Treatment Forecast by Application (2017-2027)

9.4.2.  Angioedema Treatment Market Share Forecast by Application (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Angioedema Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Angioedema Treatment Revenue and Revenue Share by Type (2017-2018)
Figure Global Corticosteroids Revenue and Growth Rate (2017-2018)
Figure Global Antihistamines Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Angioedema Treatment Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Research Organizations Revenue and Growth Rate (2017-2018)
Table Global Angioedema Treatment Revenue by Regions (2017-2018)
Figure North America Angioedema Treatment Growth Rate (2017-2018)
Figure North America Angioedema Treatment Revenue and Growth Rate (2017-2018)
Figure North America Angioedema Treatment by Countries (2017-2018)
Figure North America Angioedema Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Angioedema Treatment Growth Rate (2017-2018)
Figure United States Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Angioedema Treatment Growth Rate (2017-2018)
Figure Canada Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Angioedema Treatment Growth Rate (2017-2018)
Figure Mexico Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Angioedema Treatment Growth Rate (2017-2018)
Figure Europe Angioedema Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Angioedema Treatment by Countries (2017-2018)
Figure Europe Angioedema Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Angioedema Treatment Growth Rate (2017-2018)
Figure Germany Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Angioedema Treatment Growth Rate (2017-2018)
Figure France Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Angioedema Treatment Growth Rate (2017-2018)
Figure UK Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Angioedema Treatment Growth Rate (2017-2018)
Figure Russia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Angioedema Treatment Growth Rate (2017-2018)
Figure Italy Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Angioedema Treatment Growth Rate (2017-2018)
Figure Rest of Europe Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Angioedema Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Angioedema Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Angioedema Treatment by Countries (2017-2018)
Figure Asia-Pacific Angioedema Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Angioedema Treatment Growth Rate (2017-2018)
Figure China Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Angioedema Treatment Growth Rate (2017-2018)
Figure Japan Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Angioedema Treatment Growth Rate (2017-2018)
Figure Korea Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Angioedema Treatment Growth Rate (2017-2018)
Figure India Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Angioedema Treatment Growth Rate (2017-2018)
Figure Southeast Asia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Angioedema Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Angioedema Treatment Growth Rate (2017-2018)
Figure South America Angioedema Treatment Revenue and Growth Rate (2017-2018)
Figure South America Angioedema Treatment by Countries (2017-2018)
Figure South America Angioedema Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Angioedema Treatment Growth Rate (2017-2018)
Figure Brazil Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Angioedema Treatment Growth Rate (2017-2018)
Figure Argentina Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Angioedema Treatment Growth Rate (2017-2018)
Figure Columbia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Angioedema Treatment Growth Rate (2017-2018)
Figure Rest of South America Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Angioedema Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Angioedema Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Angioedema Treatment by Countries (2017-2018)
Figure Middle East and Africa Angioedema Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Angioedema Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Angioedema Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Angioedema Treatment Growth Rate (2017-2018)
Figure Egypt Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Angioedema Treatment Growth Rate (2017-2018)
Figure Nigeria Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Angioedema Treatment Growth Rate (2017-2018)
Figure South Africa Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Angioedema Treatment Growth Rate (2017-2018)
Figure Turkey Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Angioedema Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Angioedema Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table AstraZeneca Angioedema Treatment Financial Overview
Table Merck & Co. Angioedema Treatment Financial Overview
Table F.Hoffmann-La Roche AG Angioedema Treatment Financial Overview
Table Sanofi SA Angioedema Treatment Financial Overview
Table Valeant Pharmaceuticals International Angioedema Treatment Financial Overview
Table AstraZeneca Angioedema Treatment Financial Overview
Table GlaxoSmithKline Angioedema Treatment Financial Overview
Figure Global Angioedema Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Angioedema Treatment Market Forecast by Regions (2018-2025)
Figure North America Angioedema Treatment Market Forecast (2018-2025)
Figure United States Angioedema Treatment Market Forecast (2018-2025)
Figure Canada Angioedema Treatment Market Forecast (2018-2025)
Figure Mexico Angioedema Treatment Market Forecast (2018-2025)
Figure Europe Angioedema Treatment Market Forecast (2018-2025)
Figure Germany Angioedema Treatment Market Forecast (2018-2025)
Figure France Angioedema Treatment Market Forecast (2018-2025)
Figure UK Angioedema Treatment Market Forecast (2018-2025)
Figure Russia Angioedema Treatment Market Forecast (2018-2025)
Figure Italy Angioedema Treatment Market Forecast (2018-2025)
Figure Rest of Europe Angioedema Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Angioedema Treatment Market Forecast (2018-2025)
Figure China Angioedema Treatment Market Forecast (2018-2025)
Figure Japan Angioedema Treatment Market Forecast (2018-2025)
Figure Korea Angioedema Treatment Market Forecast (2018-2025)
Figure India Angioedema Treatment Market Forecast (2018-2025)
Figure Southeast Asia Angioedema Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Angioedema Treatment Market Forecast (2018-2025)
Figure South America Angioedema Treatment Market Forecast (2018-2025)
Figure Brazil Angioedema Treatment Market Forecast (2018-2025)
Figure Argentina Angioedema Treatment Market Forecast (2018-2025)
Figure Columbia Angioedema Treatment Market Forecast (2018-2025)
Figure Rest of South America Angioedema Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Angioedema Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Angioedema Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Angioedema Treatment Market Forecast (2018-2025)
Figure Egypt Angioedema Treatment Market Forecast (2018-2025)
Figure Nigeria Angioedema Treatment Market Forecast (2018-2025)
Figure South Africa Angioedema Treatment Market Forecast (2018-2025)
Figure Turkey Angioedema Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Angioedema Treatment Market Forecast (2018-2025)
Figure Global Angioedema Treatment Forecast by Type (2018-2025)
Figure Global Angioedema Treatment Market Share Forecast by Type (2018-2025)
Figure Global Angioedema Treatment Forecast by Type (2018-2025)
Figure Global Angioedema Treatment Forecast by Application (2018-2025)
Figure Global Angioedema Treatment Market Share Forecast by Application (2018-2025)
Figure Global Angioedema Treatment Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*